Significant Accounting Policies - Schedule of Concentrations of Risk Percentage (Details) - Customer Concentration Risk	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020
Customer A | Accounts Receivable, Net
Significant Accounting Policies [Line Items]
Concentration risk, percentage			16.10%		19.10%
Customer B | Accounts Receivable, Net
Significant Accounting Policies [Line Items]
Concentration risk, percentage					12.20%
Customer C | Revenue
Significant Accounting Policies [Line Items]
Concentration risk, percentage		10.30%
Customer D | Accounts Receivable, Net
Significant Accounting Policies [Line Items]
Concentration risk, percentage			14.80%
Genentech, Inc. and Roche Group | Revenue
Significant Accounting Policies [Line Items]
Concentration risk, percentage	39.80%	48.10%	42.60%	55.10%